Hyperosmolality Causes Growth Arrest of Murine Kidney Cells
INDUCTION OF GADD45 AND GADD153 BY OSMOSENSING VIA STRESS-ACTIVATED PROTEIN KINASE 2*

Dietmar KültzDagger , Samira Madhany§, and Maurice B. Burg

From the Laboratory of Kidney and Electrolyte Metabolism, NHLBI, National Institutes of Health, Bethesda, Maryland 20892-1603

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Murine kidney cells of the inner medullary collecting duct (mIMCD) were exposed to either isosmotic (300 mosmol/kg) or hyperosmotic medium (isosmotic medium + 150 mM NaCl) after seeding. We determined cell numbers, total nucleic acid, DNA, and RNA contents in both groups every day for a total period of 7 days. Based on all 4 parameters it was evident that growth of mIMCD3 cells is arrested for ~18 h following onset of hyperosmolality. However, none of the parameters measured indicated cell death because of hyperosmolality. Growth curves of hyperosmotic samples were shifted compared with isosmotic samples showing a gap of 18 h but had the same shape otherwise. We demonstrated that at 24 and 48 h after onset of hyperosmolality, but not in isosmotic controls, growth arrest and DNA damage-inducible (GADD) proteins GADD45 and GADD153 are strongly induced. This result is consistent with growth arrest observed in hyperosmotic medium. We tested if mitogen- and stress-activated protein kinase (SAPK) cascades are involved in osmosignaling that leads to GADD45 and GADD153 induction. Using phosphospecific antibodies we showed that extracellular signal-regulated kinases 1 and 2 (ERK), SAPK1 (JNK), and SAPK2 (p38) are hyperosmotically activated in mIMCD cells. Hyperosmotic GADD45 induction was significantly decreased by 37.5% following inhibition of the SAPK2 pathway, whereas it was significantly increased (65.2%) after inhibition of the ERK pathway. We observed similar, although less pronounced effects of SAPK2 and ERK inhibition on hyperosmotic GADD153 induction. In conclusion, we demonstrate that mIMCD cells arrest growth following hyperosmotic shock, that this causes strong induction of GADD45 and GADD153, that GADD induction is partially dependent on osmosignaling via SAPK2 and ERK, and that SAPK2 and ERK pathways have opposite effects on GADD expression.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Osmotic stress severely compromises functioning of eukaryotic cells, which must maintain homeostasis of inorganic ions as a prerequisite for metabolic processes to proceed properly. When eukaryotic cells are osmotically stressed they generally respond by regulating three functionally distinct sets of proteins. First, molecular chaperones and heat shock proteins are activated to counteract destabilization and unfolding of proteins because of osmotic stress (1, 2). Second, enzymes or transmembrane transporters regulating compatible osmolyte levels are activated upon hyperosmotic stress and deactivated upon hyposmotic stress (3, 4). Compatible organic osmolyte concentrations are regulated such that homeostasis of inorganic ion concentrations after disturbance because of cell volume regulation is reestablished. Third, proteins that define structural and functional aspects of specialized cell types at different osmolalities and certain immediate early genes are tightly regulated by osmotic strength. This is particularly the case in epithelial cells of animals that maintain osmotic homeostasis of their extracellular body fluids (osmoregulators), e.g. mammalian kidney cells (5) or teleost gill cells (6, 7).

In this study we asked first if a fourth group of proteins, the growth arrest and DNA damage-inducible (GADD)1 gene products, that are commonly induced by stressors such as UV radiation, chemical carcinogens, starvation, etc. are also induced by osmotic stress. These proteins have been shown to be associated with growth arrest and to be involved in DNA damage repair in a variety of cell types (8). In vitro approaches have demonstrated strong effects of osmotic stress on DNA structure and function (9-12). On the contrary, prior to this study it was unknown whether animal cells are able to arrest their growth and induce GADD expression when exposed to osmotic stress or simply undergo cell death if a certain osmotic threshold is exceeded.

Our second objective was to test whether osmosensing mitogen-activated protein kinase (MAPK) signal transduction pathways are involved in osmotic regulation of GADD expression. The MAPK family of protein kinases contains many subfamilies of which at least 5 are represented by paralogous isoforms in vertebrates (13). Two of these MAPK subfamilies (the stress-activated protein kinases SAPK1 = JNK and SAPK2 = p38) display the highest degree of homology to the osmosensing yeast MAPK high osmolarity glycerol kinase 1 (HOG1) and are able to complement Delta HOG1 mutants (14, 15). However, we previously demonstrated that SAPK1 and SAPK2 are not necessary for transducing hyperosmotic stress to the aldose reductase osmotic responsive enhancer element and that osmoregulation of this mammalian enzyme differs in this respect from osmolyte-producing enzymes in yeast (16). We continued to search for possible targets of MAPK-osmosensing pathways and found that GADD protein expression is at least partially activated by SAPK2 phosphorylation and inhibited by extracellular signal-regulated kinase (ERK) phosphorylation. A working model explaining these results is presented and the implications of our findings for strategies of cellular adaptation to osmotic stress are discussed.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cell Culture and Experimental Design-- Murine inner medullary collecting duct (mIMCD) cells (17) of passage numbers 12-16 were used for all experiments. Monolayers were cultured in medium consisting of 45% Hams-F12 (Life Technologies, Inc.), 45% DMEM (Life Technologies, Inc.), and 10% fetal bovine serum (Life Technologies, Inc.). The final osmolality of this medium was 300 ± 5 mosmol/kg water as checked using a freezing point osmometer (µOsmette, Precision Instruments). 10x hyperosmotic medium of 3000 ± 5 mosmol/kg water was prepared by addition of NaCl to regular growth medium. Exposure of mIMCD cells to either iso- or hyperosmotic medium was initiated during all experiments by addition of one-tenth of the total volume of either regular medium or 10x hyperosmotic medium, respectively. Quick mixing with regular medium was achieved by gently swirling the dish. Final osmolality in dishes exposed to hyperosmolality was 600 ± 5 mosmol/kg water as checked using a freezing point osmometer (µOsmette, Precision Instruments). mIMCD cells were incubated at 37 °C, 5% CO2 during all experiments.

Determination of Growth Characteristics-- mIMCD cells were seeded at a density of 7 × 105 cells in 10-cm dishes and allowed to attach for 6 h. At this time half of the dishes were exposed to hyperosmotic medium while the other half served as isosmotic controls (see above). Cells grown in either of these two different osmotic environments were harvested at the following times after seeding: 6, 30, 54, 78, 102, 126, and 150 h. Cell harvest was achieved by trypsinization (18). 2 aliquots were used for counting cells in a Neubauer hemocytometer, and the remainder was centrifuged at 500 × g for 2 min. The resulting cell pellets were stored frozen at -80 °C. Cell pellets were analyzed for total nucleic acid, DNA, and RNA contents using an assay based on binding of a fluorescent dye to cellular nucleic acids (CyQuant®, Molecular Probes). All assays were performed according to the manufacturer's instructions (Molecular Probes), and fluorescence intensity was measured with an SLT Fluostar fluorescence microplate reader (Tecan). The excitation wavelength was set at 485 nm, and fluorescence intensity was recorded at an emission wavelength of 538 nm.

Inhibitor Experiments-- To prevent targets of SAPK2 and ERK pathways from being activated by hyperosmolality we utilized highly specific inhibitors (19, 20) of SAPK2 (SB 203580, Calbiochem) and MEK (PD98059, Calbiochem). Both compounds were administered 2 h prior to onset of either hyperosmotic or isosmotic conditions to allow for sufficient time for diffusion into cells and complete inhibition. Inhibitors were dissolved in ethanol in the dark to yield 25 mM stock solutions (1000×), which were prepared fresh daily. 8 µl of stock solution was added to 8 ml of medium. Final concentration of both inhibitors was 25 µM.

Sample Preparation and Electrophoresis-- Cells were rinsed twice with phosphate-buffered saline of the same osmolality as medium and lysed with 100 µl of lysis buffer per dish. Lysis buffer was prepared fresh and composed as follows: 100 mmol/liter NaF, 50 mmol/liter Tris, 250 µmol/liter thimerosal, 1% v/v igepal, 16 mmol/liter Chaps, 5 mmol/liter activated NaVO4, 50 mg/l Pefabloc® (Boehringer Mannheim), 100 mg/liter leupeptin, 10 mg/liter aprotinin, and 100 mg/liter pepstatin A. Cell lysates were scraped off the dishes, transferred to Teflon/glass homogenizers (Wheaton), and homogenized by applying 10 strokes on ice water. After centrifugation for 30 min at 15,000 × g and 4 °C the supernatant was aliquoted and stored at -80 °C. Protein content was measured using the bicinchoninic acid method (21) using a kit (Pierce). Proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Equal amounts of protein (40 µg) were loaded to each lane of 4-20% acrylamide/Tris/glycine gradient gels. At least one lane per gel was loaded with prestained molecular weight standards (Bio-Rad). Electrophoresis was performed at 125 V constant voltage, and gels were processed by Western blotting immediately following electrophoresis.

Western Blotting and Immunodetection-- Gels were rinsed briefly in transfer buffer (composition: 25 mM Tris, 200 mM glycine, 20% methanol) whereafter proteins were blotted onto Immobilon P membrane (Millipore) at 1 mA/cm2 constant current for 90 min using a Multiphor II NovaBlot semidry blotting unit (Amersham Pharmacia Biotech). Membranes were immersed in blocking buffer (composition: 137 mmol/liter NaCl, 20 mmol/liter Tris, pH 7.6, with HCl, 0.1% v/v Tween-20, 5% w/v nonfat dry milk, 0.02% w/v thimerosal) and kept at 4 °C overnight. Immunodetection procedures were carried out for stress-activated protein kinase 1 (SAPK1 = JNK), stress-activated protein kinase 2 (SAPK2 = p38), ERK1 and ERK2, phospho-SAPK1, phospho-SAPK2, phospho-ERK, GADD45, and GADD153. First, blots were incubated for 3 h in primary antibody solution (composition: same as blocking buffer except that nonfat dry milk had been replaced by an equal amount of bovine serum albumin). The following primary antibodies were used: phospho-SAPK1 (New England Biolabs 9251S, 1:2000), phospho-SAPK2 (New England Biolabs 9211S, 1:2000), phospho-ERK (New England Biolabs 9101, 1:2000), SAPK1 (New England Biolabs 9252, 1:2000), SAPK2 (New England Biolabs 9212, 1:2000), ERK (New England Biolabs 9102, 1:2000), GADD45 (Santa Cruz Biotechnology sc-792, 1:10,000), GADD153 (Santa Cruz Biotechnology sc-575, 1:2000). After three 5-min washes in blocking buffer the blots were incubated for 1 h with secondary antibody (New England Biolabs 7051-1, goat anti-rabbit IgG linked to alkaline phosphatase) diluted 1:2000 in blocking buffer. After another three 5-min washes in blocking buffer and two additional 5-min washes in blocking buffer devoid of milk the blots were finally incubated for 5 min with enhanced chemiluminescence (ECL) reagent (CDP-Star, New England Biolabs). All incubations except blocking were done at room temperature on a laboratory rotating shaker. Blots developed with ECL reagent were wrapped in plastic wrap, exposed to ECL Hyperfilm (Amersham Pharmacia Biotech), and developed using an automatic film developer (Kodak M-35 X-Omat).

Densitometry and Statistics-- Films were scanned using a PDSI-90 densitometer (Molecular Dynamics) and analyzed with ImageQuant densitometry software (Molecular Dynamics). For each blot an exposure time was chosen that gave good intensity of bands without exceeding the sensitivity of the film. Intensity of individual bands was quantified from an identical area by calculating the densitometric volume of this area and are given as densitometric volume units (DVU). Background correction was set to local median. All values were normalized to a reference band from the same sample that was set 100% on all films. Statistical data analysis was done using StatMost32 software. Time series effects were evaluated by analysis of variance and differences between values within a single series by Student-Newman-Keuls test. Differences between pairs of data (hyper- versus isosmotic) at the same time point were tested for significance by F-test followed by either paired t test or Mann-Whitney test. All experiments were replicated between 4 and 6 times.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

mIMCD cells arrest their growth after medium osmolality is increased from 300 to 600 mosmol/kg water by addition of NaCl. Cell numbers double during the first day after seeding in isosmotic medium (Fig. 1A). This initial growth is suppressed by hyperosmolality (Fig. 1A). Starting from day 5 the difference in cell numbers diminishes because cell monolayers start to reach confluency by this time (Fig. 1A). The duration of growth arrest was approximately 18 h as illustrated by the magnitude of shift of the growth curve after hyperosmotic exposure. Total nucleic acid content showed the same pattern compared with cell numbers and also illustrated growth arrest after hyperosmotic shock (Fig. 1B). Interestingly, the difference in DNA content between iso- and hyperosmotic samples is very small (Fig. 1C), whereas it is very large for RNA content (Fig. 1D). These data suggest that growth of mIMCD cells is arrested in G2 rather than G1 phase. Presumably, DNA replication rate is not strongly affected by hyperosmolality, whereas mitosis is delayed. This is reflected in low abundance of cellular RNA versus DNA (Fig. 1, C and D). In addition, our data illustrating a strong decrease in RNA content (Fig. 1D) may reflect an inhibition of transcription by hyperosmolality.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Hyperosmotic induction of growth arrest in mIMCD cells. Cells grown in isosmotic medium (300 mosmol/kg water) are symbolized by open squares, and cells grown in hyperosmotic medium (600 mosmol/kg water) by filled circles. A, cell numbers per 10-cm dish illustrating 18 h growth arrest that results in a shift of the growth curve to the right; B, total nucleic acid content per 10-cm dish; C, DNA content per 10-cm dish; D, RNA content per 10-cm dish. Data represent means ± S.E., n = 4. Asterisks symbolize significant effects of hyperosmolality (p < 0.05).

Because we were able to demonstrate that mIMCD cells undergo a period of 18 h of growth arrest after hyperosmotic shock we tested if GADD proteins are induced by hyperosmolality. Indeed, we found that two GADD proteins, GADD45 (Fig. 2A) and GADD153 (Fig. 2B), are strongly induced by hyperosmolality. Time courses of induction are depicted for GADD45 (Fig. 2C) and GADD153 (Fig. 2D). The levels of GADD45 and GADD153 expression are very low in isosmotic controls and during the first hours following hyperosmotic exposure, but they increase dramatically 24-48 h after onset of hyperosmolality (Fig. 2). Maximum induction of both GADD45 (Fig. 2C) and GADD153 (Fig. 2D) was observed at 24 h in cells exposed to hyperosmotic medium.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 2.   Hyperosmotic induction of GADD protein expression in mIMCD cells. One example of time courses of expression in isosmotic and hyperosmotic medium is depicted for GADD45 (A) and GADD153 (B). Results of quantitative densitometric analysis are depicted for GADD45 (C) and GADD153 (D). Open squares with S.E. at bottom symbolize samples exposed to isosmotic medium and filled circles with S.E. on top symbolize samples exposed to hyperosmotic medium. Data are plotted as DVU  see "Experimental Procedures") and represent means ± S.E., n = 4. Asterisks symbolize significant effects of hyperosmolality (p < 0.05). Note that there is an axis break and change of units of time after 60 min.

Our next goal was to get insight into osmosensing signal transduction pathways that are responsible for hyperosmotic GADD45 and/or GADD153 induction. To that end we determined time courses of activation of a number of protein kinase cascades that have previously been shown to be important for osmosensing signal transduction. We found that in mIMCD cells, three subfamilies of MAPKs are activated. These include the stress-activated protein kinase 1 (SAPK1 = JNK), SAPK2 (p38), and extracellular signal-regulated kinases 1 and 2 (ERK). Phosphorylation-mediated hyperosmotic activation of these protein kinases is illustrated in Fig. 3. Hyperosmotic activation of ERK (Fig. 3A, p42 and p44) was much weaker compared with SAPK1 (Fig. 3B) and SAPK2 (Fig. 3C). In addition, ERK also showed a considerable amount of constitutive phosphorylation, which was not the case for SAPK1 or SAPK2 (Fig. 3). ERK phosphorylation reached its maximum after 5 min of exposure to hyperosmotic medium (Fig. 3D), whereas maximal SAPK1 phosphorylation was obtained after 1 h in hyperosmotic medium (Fig. 3E). Hyperosmotic activation of p54 SAPK1 was slowest (Fig. 3E) followed by p46 SAPK1 (Fig. 3E). In contrast, the phosphorylation kinetics of SAPK2 (Fig. 3F) and ERK (Fig. 3D) was much faster with maximal or near maximal activities achieved already within 5 min of hyperosmotic treatment. Hyperosmotically induced phosphorylation of all three MAPK subfamilies was transient and completely reversed within 6 h of onset of hyperosmotic exposure (Fig. 3).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 3.   Hyperosmotic induction of MAPK phosphorylation in mIMCD cells. One example of time courses of phosphorylation in isosmotic and hyperosmotic medium is depicted for the following MAPKs: ERK (p44, p42) (A), SAPK1 (JNK) (B), and SAPK2 (p38) (C). Results of quantitative densitometric analysis are depicted for ERK (D), SAPK1 (E), and SAPK2 (F). Squares with S.E. at bottom symbolize samples exposed to isosmotic medium, and circles with S.E. on top symbolize samples exposed to hyperosmotic medium. ERK1 (p44) (D) and p46 SAPK (E) are depicted as closed symbols connected by continuous lines, whereas ERK2 (p42) (D) and p54 SAPK (E) are plotted as open symbols connected by dotted lines. Data are given as DVU (see "Experimental Procedures") and represent means ± S.E., n = 4. Asterisks symbolize significant effects of hyperosmolality (p < 0.05). Note that there is an axis break and change of units of time after 60 min.

Hyperosmolality did not affect the expression of any of the MAPKs analyzed within a period of 2 days (Fig. 4). Therefore changes in the abundance of these kinases can be excluded from being responsible for hyperosmotic induction of GADD45 and GADD153 expression. Interestingly, SAPK2 phosphorylation had an inhibitory effect on ERK phosphorylation even though activation of both of these MAPKs is hyperosmotically induced (Fig. 5). This cross-talk between SAPK2 and ERK pathways may explain the relatively high variability of phospho-ERK levels following hyperosmotic stress (Fig. 3D).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 4.   Hyperosmolality does not affect MAPK expression in mIMCD cells. One example of time courses of expression in isosmotic and hyperosmotic medium is depicted for the following MAPKs: ERK (p44, p42) (A), SAPK1 (JNK) (B), and SAPK2 (p38) (C). Results of quantitative densitometric analysis are depicted for ERK (D), SAPK1 (E), and SAPK2 (F). Squares with S.E. at bottom symbolize samples exposed to isosmotic medium, and circles with S.E. on top symbolize samples exposed to hyperosmotic medium. ERK1 (p44) (D) and p46 SAPK (E) are depicted as closed symbols connected by continuous lines, whereas ERK2 (p42) (D) and p54 SAPK (E) are plotted as open symbols connected by dotted lines. Data are given as DVU (see "Experimental Procedures") and represent means ± S.E., n = 4. Asterisks symbolize significant effects of hyperosmolality (p < 0.05). Note that there is an axis break and change of units of time after 60 min.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   Hyperosmotic induction of ERK is increased by inhibition of SAPK2. Panel A depicts data obtained for ERK1 (p44) phosphorylation and panel B for ERK2 (p42) phosphorylation at 30 min following onset of hyperosmotic exposure. The SAPK2-specific inhibitor SB203580 does not affect basal levels of phospho-ERK in isosmotic medium but leads to significantly higher phospho-ERK levels in hyperosmotic medium. Data are given as DVU (see "Experimental Procedures") and represent means ± S.E., n = 6. Asterisks symbolize significant effects of SB203580 (p < 0.05).

To assess whether the changes in phosphorylation of ERK and SAPK2 account for the observed induction of GADD proteins, we inhibited ERK and SAPK2 pathways using highly specific pharmacological inhibitors of MEK (specific ERK activator) and SAPK2. Inhibition of SAPK2 resulted in a 37.5% decrease in hyperosmotic GADD45 induction (Fig. 6A) and 19.6% decrease in hyperosmotic GADD153 induction (Fig. 6B). On the contrary, inhibition of the ERK pathway resulted in further potentiation of hyperosmotic GADD45 induction by 65.2% (Fig. 6A) and of GADD153 induction by 28.7% (Fig. 6B). These results suggest that hyperosmotic induction of GADD45, and to a lesser degree of GADD153, is positively regulated via SAPK2 and negatively regulated via ERK osmosensing pathways. However, because SB203580 only partially prevented the increase in GADD45 and GADD153 expression, it is clear that additional, as yet unidentified elements, are also involved in hyperosmotic GADD induction.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   Hyperosmotic induction of GADD expression is positively regulated via SAPK2 phosphorylation and counteracted by ERK phosphorylation. Panel A depicts data obtained for GADD45 expression and panel B for GADD153 expression at 24 h following onset of hyperosmotic exposure. SB203580 specifically inhibits SAPK2, and PD98059 specifically inhibits the ERK activator MEK. Neither inhibitor has an effect on basal levels of GADD45 or GADD153 in isosmotic medium. SB203580 partially suppresses and PD98059 further elevates the induction of expression of both GADD45 and GADD153 in hyperosmotic medium. Data are given as DVU (see "Experimental Procedures") and represent means ± S.E., n = 6. Asterisks symbolize significant inhibitor effects (p < 0.05).

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We demonstrate for the first time that hyperosmolality induces growth arrest of animal cells. Growth arrest of mIMCD cells persisting for 18 h appears immediately following exposure to hyperosmolality of 600 mosmol/kg water (+300 mosmol of NaCl). Our data do not indicate any cell death caused by this kind of hyperosmotic stress. However, induction and length of growth arrest clearly depend on the strength of osmotic stress. Sudden change of medium from isosmolality (300 mosmol/kg water) to hyperosmolality of 650 instead of 600 mosmol/kg water causes a significant fraction of mIMCD cells to show clear signs of cell death (data not shown). Osmotically induced growth arrest has been observed in bacteria (22) and yeast (23, 24) where it appears to be a necessary component for recovery from osmotic stress. One may speculate that these unicellular organisms as well as mIMCD cells arrest growth in situations of hyperosmotic stress to 1) provide sufficient time for adaptive responses to be activated before undergoing mitosis, and 2) redirect energetic resources from mitotic cell growth to resistance and capacity adaptations that compensate osmotic stress. The time of ~18 h that mIMCD cells are arrested in G2 corresponds to the time required for compatible organic osmolytes to accumulate during hyperosmotic stress (25).

Our data on RNA and DNA contents in mIMCD cells indicate that hyperosmolality causes G2 arrest. The minor effect of hyperosmolality on cellular DNA content is consistent with relatively undisturbed DNA replication. On the contrary, transcription may be inhibited by hyperosmotic stress as indicated by the large difference in RNA content between populations of cells grown in iso- versus hyperosmotic medium. These findings, taken together with the differences observed in growth rates based on cell numbers, indicate that mIMCD cells proceed through G1 and S phase but are arrested in G2 before starting to divide. Most DNA-damaging agents are known to cause growth arrest in G2 suggesting potential DNA damage by hyperosmolality (8). G2 arrest may have a selective advantage to cells insofar as transcription and overall metabolism are slowed down such that possible osmotic damage may be kept at minimum.

Growth arrest has been shown to strongly induce GADD gene products in a variety of cell types (26, 27). In this study we provide evidence that this paradigm holds true for hyperosmotically stressed mIMCD cells. However, only GADD45 and GADD153 are induced by osmotic stress in mIMCD cells, whereas GADD34 remains unchanged at very low levels (data not shown). Therefore, GADD45/GADD153 and GADD34 are not cooperatively regulated by osmotic stress in mIMCD cells. At present it is unknown at which level (transcriptional, posttranscriptional, or translational) GADD45 and GADD153 are primarily induced in response to osmotic stress. The elements involved in this regulation remain to be elucidated.

Currently, the function of GADD proteins is also unknown although GADD153 has been shown to dimerize with and alter the binding capacity of the CCAAT/enhancer-binding protein transcription factors (28, 29). Time courses of GADD45 and GADD153 induction are somewhat stressor-specific, being very rapid (maximum at 1 h, returning to baseline levels within 24 h) in response to DNA-damaging carcinogens and UV radiation (26, 27). In these cases it has been suggested that growth arrest, often in G1 phase, is a result of GADD induction (30, 31). Our data indicate that osmotic stress leads to a much slower but more persistent induction of GADD45 and GADD153 resembling the kinetics observed by medium depletion (32). By comparing time courses of growth arrest and GADD45/153 induction in IMCD cells it is evident that induction of GADD proteins does not precede G2 arrest in mIMCD cells. Rather, hyperosmotic GADD45/153 induction seems to be a consequence of growth arrest or occur in parallel to growth cessation. The tumor suppressor p53 has also been reported to either induce growth arrest (33) or to be induced as a result of growth arrest (32) depending on the nature of the stress and cell type.

Growth arrest and GADD protein induction were shown to be triggered by a wide variety of DNA-damaging agents, including chemical carcinogens, starvation, hypoxia, UV radiation, and other stresses (8). Moreover, GADD153 and GADD45 are specifically involved in DNA damage repair and activated in this capacity via the tumor suppressor p53 (34). Thus, it is tempting to speculate that osmotic stress leads to DNA damage that in turn triggers growth arrest and GADD45/153 induction as part of a DNA repair mechanism. The time courses of GADD45 and GADD153 induction seem to contradict this notion. These proteins are induced strongest only after mIMCD cells have resumed to grow again (at 24 h). Thus, the need for DNA repair may not be immediate anymore by the time GADD45 and GADD153 are present at highest levels. Alternatively, GADD45/153 may be involved in DNA stabilization at high osmotic strength and/or required for lifting the G2 growth arrest.

A variety of in vitro experiments employing different methodologies have convincingly demonstrated strong effects of osmotic strength on DNA structure (10, 12) and transcriptional activity (5, 9, 11). In general, transcription is severely inhibited by deviations from intracellular osmotic homeostasis that is caused by noncompatible osmolytes (9). In fact, optimization of transcriptional activity for specific (homeostatic) osmotic conditions may well represent one of the major forces leading to the extraordinary wide phylogenetic conservation of intracellular inorganic ion concentrations. This scenario is supported by our data demonstrating a large difference in RNA content between populations of cells grown in isosmotic versus hyperosmotic medium. However, despite this overall negative effect of hyperosmolality on RNA content, certain genes of particular adaptive value are induced instead of repressed under these conditions. Examples include genes for osmolyte-producing enzymes, e.g. aldose reductase, or osmolyte transporters, e.g. betaine transporter (4). In some of these genes, specific osmotically or tonicity-responsive enhancer elements have been identified in the 5'-untranslated region, and progress is being made in elucidating the molecular pathways involved in the regulation of these elements (35, 36). The adaptive value of these genes lies in the restoration of ionic homeostasis after a disturbance by replacing excessive inorganic ions with compatible osmolytes. The adaptive advantage of GADD45 and GADD153 gene expression may lie in enhanced repair of damaged DNA caused by osmotic fluctuations, but this remains to be confirmed. Alternative functions of GADD proteins may include lifting of G2 growth arrest or stabilization of DNA in unfavorable situations, e.g. during hyperosmotic stress. Similarly, it has been shown that hyperosmotic stress induces molecular chaperones that protect proteins from unfolding and degradation (1). Presently, it is not known whether osmolyte-producing enzymes and transporters, molecular chaperones, and GADD proteins are all regulated by a similar mechanism operating coordinately in situations of hyperosmotic stress or by multiple strategies. A key question remains how these genes and proteins of adaptive value are induced, whereas the majority of genes and metabolic activity seems to be repressed by osmotic stress.

To address this question we analyzed three osmosensing signal-transduction pathways for their potential to confer osmotic regulation of GADD45 and GADD153. The three pathways analyzed are all phosphorylation cascades arranged around a particular MAPK. We chose to evaluate the ERK pathway, the SAPK1 (JNK) pathway, and the SAPK2 (p38) pathway for their potential to signal GADD45 and/or GADD153 induction. Our results demonstrate that all three pathways are hyperosmotically activated in mIMCD cells, which is consistent with an independent study published recently (37). We find that differences in the kinetics of hyperosmotic activation of ERK, SAPK1, and SAPK2 exist and that activation of all three MAPK pathways was exclusively because of phosphorylation without a change in the number of kinases present. Activation kinetics was very fast for SAPK2 and ERK, and slower for SAPK1. In contrast to SAPKs, constitutive levels of phospho-ERK are significant and do not increase much after exposing mIMCD cells to hyperosmotic medium. A negative feedback mechanism might explain the early maximum and rather large fluctuations in phospho-ERK levels observed after hyperosmotic shock. Indeed, it has been demonstrated that SAPK2 activation leads to activation of a MAPK phosphatase (MKP1), which specifically dephosphorylates ERK (38).

Recent evidence suggests that the betaine transporter gene is a target of SAPK2 in Madin-Darby canine kidney cells (39). However, we previously demonstrated that SAPK-osmosensing pathways in rabbit PAP-HT25 cells do not target the osmotic responsive enhancer element of the aldose reductase gene (16). In addition, it has been demonstrated that osmolyte transporter genes are not regulated via the ERK pathway (40) or the SAPK1 pathway (41). We were therefore interested in other potential targets of MAPK-osmosensing pathways in mammalian kidney cells and tested if GADD45 and GADD153 are osmotically regulated via SAPK2 or ERK phosphorylation cascades. We find that GADD45/153 expression is positively regulated by the SAPK2 and negatively regulated by the ERK pathways (Fig. 6). The physiological significance of negative feedback regulation of phospho-ERK levels may lie in conferring signal specificity and/or to reinforce the positive effect of SAPK2 phosphorylation on GADD expression by minimizing negative effects of phospho-ERK. Because inhibition of SAPK2 only partially diminishes hyperosmotic induction of GADD proteins, other pathways are likely to be involved. One candidate is the SAPK1 (JNK) pathway, which has been shown to be involved in cell cycle regulation (42), apoptosis (43), and p53 phosphorylation (44). Unfortunately, a specific pharmacological inhibitor of SAPK1 was not readily available and a negative dominant mutant of SEK1 (MKK4) could not be employed for these studies because of side effects of the transfection procedure on GADD45 and GADD153 expression in mIMCD cells. Our current working hypothesis summarizing events leading to hyperosmotic GADD45/GADD153 induction is depicted in Fig. 7. Hyperosmolality activates SAPK2 and ERK very rapidly (within minutes) and also causes mIMCD cells to arrest their growth very rapidly. This growth arrest lasts for about 18 h. Growth arrest in G2 may be either a direct consequence of hyperosmotic inactivation of molecular components required for mitosis, or it may be mediated by SAPK1, SAPK2, ERK, or other, as yet unknown, pathways. GADD45 and GADD153 are only expressed at highest levels at the time when cells start to divide and overcome the growth arrest (24-48 h after onset of hyperosmotic stress). Induction of GADD45 and GADD153 is at least in part mediated via the SAPK2 pathway. SAPK2 reinforces its positive effect on GADD induction by inhibiting the ERK pathway, which suppresses GADD45 and GADD153 induction after hyperosmotic stress (Fig. 7). This negative feedback may be mediated by a mitogen-activated protein kinase phosphatase, which specifically dephosphorylates ERK, e.g. via mitogen-activated protein kinase phosphatase 1. Additional pathways are involved in hyperosmotic GADD45/153 induction. Potential candidates are SAPK1 and p53-dependent pathways.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 7.   Working hypothesis depicting signaling pathways involved in induction of GADD45 and GADD153 expression by hyperosmolality. GADD induction is preceded by growth arrest of mIMCD cells and may be either directly or indirectly dependent on growth arrest or a parallel response acting in concert with growth arrest. Hyperosmolality also induces levels of phospho-SAPK2 and phospho-ERK. Phospho-SAPK2 positively regulates GADD45 and GADD153 expression and is partially responsible for their hyperosmotic induction. Furthermore, SAPK2 reinforces its positive effect on GADD expression by negatively regulating phosphorylation of ERK, which inhibits GADD45 and GADD153 expression.

In conclusion, we demonstrate that hyperosmolality induces growth arrest in murine kidney (mIMCD) cells and that this apparently triggers a late induction of GADD45 and GADD153. Hyperosmotic induction of GADD45 and GADD153 is partially conferred via the SAPK2 osmosensing pathway and negatively regulated by the ERK pathway. These results stimulate further research addressing the nature of DNA-damage resulting from osmotic stress and the integration of molecular messengers in response to hyperosmolality.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Laboratory of Kidney and Electrolyte Metabolism, NHLBI, National Institutes of Health, 10 Center Dr. MSC 1603, Bldg.10, Rm. 6N260, Bethesda, MD 20892-1603. Tel.: 301-496-1268; Fax: 301-402-1443; E-mail: kultzd{at}gwgate.nhlbi.nih.gov.

§ Present address: Vanderbilt University, Box 5777, Station B, Nashville, TN 37235.

1 The abbreviations used are: GADD, growth arrest and DNA damage-inducible; MAPK, mitogen-activated protein kinase; SAPK, stress-activated protein kinase; ERK, extracellular signal-regulated kinase; mIMCD, murine inner medullary collecting duct; Chaps, 3-[(3-chloramidopropyl)dimethylammonio]-1-propanesulfonic acid; DVU, densitometric volume units.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Rauchman, M. I., Pullman, J., and Gullans, S. R. (1997) Am. J. Physiol. 42, F9-F17
  2. Burg, M. B., Kwon, E. D., and Kültz, D. (1996) FASEB J. 10, 1598-1606[Abstract/Free Full Text]
  3. Yancey, P. H., Clark, M. E., Hand, S. C., Bowlus, R. D., and Somero, G. N. (1982) Science 217, 1214-1222[Medline] [Order article via Infotrieve]
  4. Burg, M. B., Kwon, E. D., and Kültz, D. (1997) Annu. Rev. Physiol. 59, 437-455[CrossRef][Medline] [Order article via Infotrieve]
  5. Gullans, S. R., Cohen, D. M., Kojima, R., Randall, J., Brenner, B. M., Santos, B., and Chevaile, A. (1996) Kidney Int. 49, 1678-1681[Medline] [Order article via Infotrieve]
  6. Kültz, D. (1996) Am. J. Physiol. 271, C1181-C1193[Abstract/Free Full Text]
  7. Kültz, D., and Somero, G. N. (1996) J. Comp. Physiol.[B] 166, 88-100[Medline] [Order article via Infotrieve]
  8. Hollander, M. C., and Fornace, A. J., Jr. (1995) in DNA Repair Mechanisms: Impact on Human Diseases and Cancer (Vos, J.-M. H., ed), pp. 219-237, R. G. Landes Company, Georgetown, TX
  9. Vanden Broeck, J., De Loof, A., and Callaerts, P. (1992) Int. J. Biochem. 24, 1907-1916[Medline] [Order article via Infotrieve]
  10. Ivanov, V. I., Karapetian, A. T., Miniat, E. E., and Sad', Ia (1993) Mol. Biol. (Moscow) 27, 1150-1156[Medline] [Order article via Infotrieve]
  11. Douzou, P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1657-1661[Abstract]
  12. Podgornik, R., Strey, H. H., Rau, D. C., and Parsegian, V. A. (1995) Biophys. Chem. 57, 111-121[CrossRef][Medline] [Order article via Infotrieve]
  13. Kültz, D. (1998) J. Mol. Evol. 46, 571-588[Medline] [Order article via Infotrieve]
  14. Galcheva-Gargova, Z., Dérijard, B., Wu, I. H., and Davis, R. J. (1994) Science 265, 806-808[Medline] [Order article via Infotrieve]
  15. Han, J., Lee, J. D., Bibbs, L., and Ulevitch, R. J. (1994) Science 265, 808-811[Medline] [Order article via Infotrieve]
  16. Kültz, D., Garcia-Perez, A., Ferraris, J. D., and Burg, M. B. (1997) J. Biol. Chem. 272, 13165-13170[Abstract/Free Full Text]
  17. Rauchman, M. I., Nigam, S. K., Delpire, E., and Gullans, S. R. (1993) Am. J. Physiol. 265, F416-F424[Abstract/Free Full Text]
  18. Freshney, R. I. (1994) Culture of Animal Cells: a Manual of Basic Technique, Wiley-Liss, New York
  19. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R. (1995) J. Biol. Chem. 270, 27489-27494[Abstract/Free Full Text]
  20. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., and Lee, J. C. (1995) FEBS Lett. 364, 229-233[CrossRef][Medline] [Order article via Infotrieve]
  21. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Anal. Biochem. 150, 76-85[Medline] [Order article via Infotrieve]
  22. Nystrom, T., and Neidhardt, F. C. (1994) Mol. Microbiol. 11, 537-544[Medline] [Order article via Infotrieve]
  23. Boguslawski, G. (1992) J. Gen. Microbiol. 138, 2425-2432[Medline] [Order article via Infotrieve]
  24. Brewster, J. L., and Gustin, M. C. (1994) Yeast 10, 425-439[Medline] [Order article via Infotrieve]
  25. Burg, M. B. (1995) Am. J. Physiol. 268, F983-F996[Abstract/Free Full Text]
  26. Fornace, A. J. J., Nebert, D. W., Hollander, M. C., Luethy, J. D., Papathanasiou, M., Fargnoli, J., and Holbrook, N. J. (1989) Mol. Cell. Biol. 9, 4196-4203[Medline] [Order article via Infotrieve]
  27. Fornace, A. J. J., Alamo, I. J., and Hollander, M. C. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 8800-8804[Abstract]
  28. Ron, D., and Habener, J. F. (1992) Genes Dev. 6, 439-453[Abstract]
  29. Fawcett, T. W., Eastman, H. B., Martindale, J. L., and Holbrook, N. J. (1996) J. Biol. Chem. 271, 14285-14289[Abstract/Free Full Text]
  30. Smith, M. L., Chen, I. T., Zhan, Q., Bae, I., Chen, C. Y., Gilmer, T. M., Kastan, M. B., O'Connor, P. M., and Fornace, A. J. J. (1994) Science 266, 1376-1380[Medline] [Order article via Infotrieve]
  31. Barone, M. V., Crozat, A., Tabaee, A., Philipson, L., and Ron, D. (1994) Genes Dev. 8, 453-464[Abstract]
  32. Zhan, Q., Carrier, F., and Fornace, A. J. J. (1993) Mol. Cell. Biol. 13, 4242-4250[Abstract]
  33. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 7491-7495[Abstract]
  34. Zhan, Q., Bae, I., Kastan, M. B., and Fornace, A. J. J. (1994) Cancer Res. 54, 2755-2760[Abstract]
  35. Takenaka, M., Preston, A. S., Kwon, H. M., and Handler, J. S. (1994) J. Biol. Chem. 269, 29379-29381[Abstract/Free Full Text]
  36. Ferraris, J. D., Williams, C. K., Jung, K.-Y., Bedford, J. J., Burg, M. B., and Garcia-Perez, A. (1996) J. Biol. Chem. 271, 18318-18321[Abstract/Free Full Text]
  37. Berl, T., Siriwardana, G., Ao, L., Butterfield, L. M., and Heasley, L. E. (1997) Am. J. Physiol. 272, F305-F311[Abstract/Free Full Text]
  38. Bokemeyer, D., Sorokin, A., Yan, M., Ahn, N. G., Templeton, D. J., and Dunn, M. J. (1996) J. Biol. Chem. 271, 639-642[Abstract/Free Full Text]
  39. Sheikh-Hamad, D., Di Mari, J., Suki, W. N., Safirstein, R., Watts, B. A., and Rouse, D. (1998) J. Biol. Chem. 273, 1832-1837[Abstract/Free Full Text]
  40. Kwon, H. M., Itoh, T., Rim, J. S., and Handler, J. S. (1995) Biochem. Biophys. Res. Commun. 213, 975-979[CrossRef][Medline] [Order article via Infotrieve]
  41. Wojtaszek, P. A., Heasley, L. E., Siriwardana, G., and Berl, T. (1998) J. Biol. Chem. 273, 800-804[Abstract/Free Full Text]
  42. Kyriakis, J. M., and Avruch, J. (1996) Bioessays 18, 567-577[Medline] [Order article via Infotrieve]
  43. Zanke, B. W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L. A., Zon, L., Kyriakis, J., Liu, F. F., and Woodgett, J. R. (1996) Curr. Biol. 6, 606-613[Medline] [Order article via Infotrieve]
  44. Adler, V., Pincus, M. R., Minamoto, T., Fuchs, S. Y., Bluth, M. J., Brandtrauf, P. W., Friedman, F. K., Robinson, C., Chen, J. M., Wang, X. W., Harris, C. C., and Ronai, Z. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1686-1691[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.